ABVC BioPharma, Inc. Operating Lease Cost
ABVC BioPharma, Inc. (ABVC) reported Operating Lease Cost of $85.86 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-05-16
- ABVC BioPharma, Inc. operating lease, cost for the quarter ending 2022-03-31 was $85.86K, a 8.89% increase year-over-year.
- ABVC BioPharma, Inc. operating lease, cost for the quarter ending 2021-12-31 was $85.09K, a 18.20% decline year-over-year.
- ABVC BioPharma, Inc. operating lease, cost for the quarter ending 2021-09-30 was $85.00K, a 7.99% increase year-over-year.
- ABVC BioPharma, Inc. operating lease, cost for the quarter ending 2021-06-30 was $86.28K, a 12.01% increase year-over-year.
- ABVC BioPharma, Inc. operating lease, cost for fiscal 2021 was $335.21K, a 0.61% decline from fiscal 2020.
- ABVC BioPharma, Inc. operating lease, cost for fiscal 2020 was $337.28K, a 11.89% increase from fiscal 2019.
- ABVC BioPharma, Inc. operating lease, cost for fiscal 2019 was $301.44K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2022-03-31 | $85.86K 10-Q · filed 2022-05-16 | $170.94K derived: sum of 2 quarters · filed 2022-05-16 | $255.94K derived: sum of 3 quarters · filed 2022-05-16 | $342.22K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-12-31 | $85.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $170.08K derived: sum of 2 quarters · filed 2022-03-31 | $256.36K derived: sum of 3 quarters · filed 2022-03-31 | $335.21K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $171.28K derived: sum of 2 quarters · filed 2021-11-15 | $250.12K 10-Q · filed 2021-11-15 | $354.14K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-06-30 | $86.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $165.13K 10-Q · filed 2021-08-12 | $269.15K derived: sum of 3 quarters · filed 2022-05-16 | $347.85K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-03-31 | $78.85K 10-Q · filed 2022-05-16 | $182.87K derived: sum of 2 quarters · filed 2022-05-16 | $261.57K derived: sum of 3 quarters · filed 2022-05-16 | $338.60K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $104.02K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $182.72K derived: sum of 2 quarters · filed 2022-03-31 | $259.75K derived: sum of 3 quarters · filed 2022-03-31 | $337.28K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $78.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $155.74K derived: sum of 2 quarters · filed 2021-11-15 | $233.26K 10-Q · filed 2021-11-15 | $338.78K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $77.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $154.56K 10-Q · filed 2021-08-12 | $260.07K derived: sum of 3 quarters · filed 2021-08-12 | $321.55K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $77.53K 10-Q · filed 2021-05-10 | $183.04K derived: sum of 2 quarters · filed 2021-05-10 | $244.52K derived: sum of 3 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $105.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $166.99K derived: sum of 2 quarters · filed 2021-03-16 | $301.44K 10-K · filed 2021-03-16 | $73.80K 10-Q · filed 2020-06-29 | |
| 2019-09-30 | $61.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $195.92K 10-Q · filed 2020-11-17 | |||
| 2019-06-30 | $134.44K 10-Q · filed 2020-08-14 |